1M views · 23K reactions | Dr. Soon-Shiong said nearly 1,000 patients have been treated successfully with Anktiva, many after standard treatments failed. He reports patients with bladder cancer alive 10 years later, metastatic pancreatic cancer patients surviving six years and complete remissions across multiple cancer types. More: https://www.newsnationnow.com/health/anktiva-patients-results/ | NewsNation | Facebook

2M views · 54K reactions | Anktiva, according to its ImmunityBio, is the first FDA-approved immunotherapy that activates what’s called a natural killer cell to target and kill non-muscle-invasive bladder cancer cells. More: https://www.newsnationnow.com/health/newsnation-special-killing-cancer-treatment-soon-shiong/ | NewsNation | Facebook